Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method
Pharmaceuticals · 08.01.2025 · 18 (1) · 62
DOI: 10.3390/ph18010062 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 08.01.2025. Verfasst von Qiu-Shi Feng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinic…. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 354 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Background
Tumors, as intricate ecosystems, comprise oncocytes and the highly dynamic tumor stroma. Tumor stroma, representing the non-cancerous and non-cellular composition of the tumor microenvironment (TME), plays a crucial role in oncogenesis and progression, through its interactions with biological, chemical, and mechanical signals. This review aims to analyze the challenges of stroma mimicry models, and highlight advanced personalized co-culture approaches for recapitulating tumor stroma using patient-derived tumor organoids (PDTOs).
Methods
This review synthesizes findings from recent studies on tumor stroma composition, stromal remodeling, and the spatiotemporal heterogeneities of the TME. It explores popular stroma-related models, co-culture systems integrating PDTOs with stromal elements, and advanced techniques to improve stroma mimicry.
Results
Stroma remodeling, driven by stromal cells, highlights the dynamism and heterogeneity of the TME. PDTOs, derived from tumor tissues or cancer-specific stem cells, accurately mimic the tissue-specific and genetic features of primary tumors, making them valuable for drug screening. Co-culture models combining PDTOs with stromal elements effectively recreate the dynamic TME, showing promise in personalized anti-cancer therapy. Advanced co-culture techniques and flexible combinations enhance the precision of tumor-stroma recapitulation.
Conclusions
PDTO-based co-culture systems offer a promising platform for stroma mimicry and personalized anti-cancer therapy development. This review underscores the importance of refining these models to advance precision medicine and improve therapeutic outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research C…
- Division of Oral and Maxillofacial Surgery, Columbia Irving Medical Center, New York City, NY 10027, USA.
ORCID-Profile: Xiao-Feng Shan, Shang Xie
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Feng, Q. S., Shan, X. F., Yau, V., Cai, Z. G., & Xie, S. (2025). Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method. Pharmaceuticals, 18(1), 62. https://doi.org/10.3390/ph18010062
Vancouver
Feng QS, Shan XF, Yau V, Cai ZG, Xie S. Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method. Pharmaceuticals. 2025;18(1):62. doi:10.3390/ph18010062
BibTeX
@article{Feng2025,
author = {Feng, Qiu-Shi and Shan, Xiao-Feng and Yau, Vicky and Cai, Zhi-Gang and Xie, Shang},
title = {Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {1},
pages = {62},
doi = {10.3390/ph18010062}
}
EUVIMED